Monocyte phenotype and extracellular vesicles in HIV-1, HIV-2, and HIV-1/2 dual infection.
Journal
AIDS (London, England)
ISSN: 1473-5571
Titre abrégé: AIDS
Pays: England
ID NLM: 8710219
Informations de publication
Date de publication:
01 10 2023
01 10 2023
Historique:
medline:
31
8
2023
pubmed:
21
7
2023
entrez:
21
7
2023
Statut:
ppublish
Résumé
AIDS-defining illness develops at higher CD4 + T-cell counts in individuals infected with HIV-2 compared with HIV-1-infected, which suggests that the two types of HIV may have different effects on other compartments of the immune system. We here investigate monocyte phenotype, activation and macrophage-derived extracellular vesicles in individuals with different HIV types. Cross-sectional. ART-naive HIV-1 ( n = 83), HIV-2 ( n = 63), and HIV-1/2 dually positive ( n = 27) participants were recruited in Bissau, Guinea-Bissau, together with HIV-negative controls ( n = 26). Peripheral blood mononuclear cells (PBMCs) were isolated and analyzed by flow cytometry for monocyte phenotype and activation, and plasma was analyzed for extracellular vesicle forms of CD163 and CD206. Compared with HIV-negative controls, all groups of HIV-positive participants had a skewed monocyte phenotype with a higher proportion of intermediate monocytes, increased CD163 expression and elevated serum levels of the inflammatory biomarkers soluble (s)CD163 and sCD206. HIV-2-positive participants had lower CD163 monocyte expression than HIV-1-positive participants, regardless of HIV RNA or CD4 + cell count. Levels of sCD206 extracellular vesicles were increased in all HIV groups, and higher in HIV-1 compared with HIV-2-positive participants. The monocyte phenotype of HIV-2-positive participants deviated less from healthy controls than did HIV-1 participants. HIV-2-positive participants also had a lower concentration of extracellular CD206 vesicles compared with HIV-1-positive participants. This does not explain the difference in AIDS development.
Identifiants
pubmed: 37475710
doi: 10.1097/QAD.0000000000003660
pii: 00002030-990000000-00306
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1773-1781Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Références
Andersson S, Norrgren H, da Silva Z, Biague A, Bamba S, Kwok S, et al. Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection . Arch Intern Med 2000; 160:3286–3293.
Esbjörnsson J, Månsson F, Kvist A, da Silva ZJ, Andersson S, Fenyö EM, et al. Sweden and Guinea-Bissau Cohort Research Group. Long-term follow-up of HIV-2-related AIDS and mortality in Guinea-Bissau: a prospective open cohort study . Lancet HIV 2018; S2352–S3018.
Esbjörnsson J, Jansson M, Jespersen S, Månsson F, Hønge BL, Lindman J, et al. HIV-2 as a model to identify a functional HIV cure . AIDS Res Ther 2019; 16:24.
Prabhu VM, Singh AK, Padwal V, Nagar V, Patil P, Patel V. Monocyte based correlates of immune activation and viremia in HIV-infected long-term non-progressors . Front Immunol 2019; 10:2849.
Funderburg NT, Zidar DA, Shive C, Lioi A, Mudd J, Musselwhite LW, et al. Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome . Blood 2012; 120:4599–4608.
Bai R, Li Z, Lv S, Wang R, Hua W, Wu H, Dai L. Persistent inflammation and non-AIDS comorbidities during ART: coming of the age of monocytes . Front Immunol 2022; 13:820480.
Kruize Z, Kootstra NA. The role of macrophages in HIV-1 persistence and pathogenesis . Front Microbiol 2019; 10:2828.
Santos-Costa Q, Lopes MM, Calado M, Azevedo-Pereira JM. HIV-2 interaction with cell coreceptors: amino acids within the V1/V2 region of viral envelope are determinant for CCR8, CCR5 and CXCR4 usage . Retrovirology 2014; 11:99.
Møller HJ, Peterslund NA, Graversen JH, Moestrup SK. Identification of the hemoglobin scavenger receptor/CD163 as a natural soluble protein in plasma . Blood 2002; 99:378–380.
Kristiansen M, Graversen JH, Jacobsen C, Jacobsen C, Sonne O, Hoffman HJ, et al. Identification of the haemoglobin scavenger receptor . Nature 2001; 409:198–201.
Lauridsen KM, Hokland M, Al-Karradi S, Møller HJ, Donskov F, Andersen MN. Soluble CD163: a novel independent prognostic biomarker in patients with metastatic renal cell carcinoma . Cancer Immunol Immunother 2023; 72:461–473.
Hønge BL, Andersen MN, Jespersen S, Medina C, Correira FG, Jakobsen MR, et al. Bissau HIV cohort study group. Brief report: macrophage activation in HIV-2-infected patients is less affected by antiretroviral treatment-sCD163 in HIV-1, HIV-2, and HIV-1/2 dually infected patients . J Acquir Immune Defic Syndr 2016; 72:254–258.
Knudsen TB, Ertner G, Petersen J, Møller HJ, Moestrup SK, Eugen-Olsen J, et al. Plasma soluble CD163 level independently predicts all-cause mortality in HIV-1-infected individuals . J Infect Dis 2016; 214:1198–1204.
Rødgaard-Hansen S, Rafique A, Christensen PA, Maniecki MB, Sandahl TD, Nexø E, Møller HJ. A soluble form of the macrophage-related mannose receptor (MR/CD206) is present in human serum and elevated in critical illness . Clin Chem Lab Med 2014; 52:453–461.
Etzerodt A, Maniecki MB, Møller K, Møller HJ, Moestrup SK. Tumor necrosis factor α-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163 . J Leukoc Biol 2010; 88:1201–1205.
Nielsen MC, Andersen MN, Rittig N, Rødgaard-Hansen S, Grønbaek H, Moestrup SK, et al. The macrophage-related biomarkers sCD163 and sCD206 are released by different shedding mechanisms . J Leukoc Biol 2019; 106:1129–1138.
Etzerodt A, Berg RMG, Plovsing RR, Andersen MN, Bebien M, Habbeddine M, et al. Soluble ectodomain CD163 and extracellular vesicle-associated CD163 are two differently regulated forms of ‘soluble CD163’ in plasma . Sci Rep 2017; 7:40286.
Nielsen MC, Andersen MN, Grønbæk H, Damgaard Sandahl T, Møller HJ. Extracellular vesicle-associated soluble CD163 and CD206 in patients with acute and chronic inflammatory liver disease . Scand J Gastroenterol 2020; 55:588–596.
Cavaleiro R, Tendeiro R, Foxall RB, Soares RS, Baptista AP, Gomes P, et al. Monocyte and myeloid dendritic cell activation occurs throughout HIV type 2 infection, an attenuated form of HIV disease . J Infect Dis 2013; 207:1730–1742.
Iannetta M, Isnard S, Manuzak J, Guillerme JB, Notin M, Bailly K, et al. Conventional dendritic cells and Slan+ monocytes during HIV-2 infection . Front Immunol 2020; 11:1658.
Ancuta P, Kamat A, Kunstman KJ, Kim EY, Autissier P, Wurcel A, et al. Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients . PloS One 2008; 3:e2516.
Fernandes SM, Pires AR, Matoso P, Ferreira C, Nunes-Cabaço H, Correia L, et al. HIV-2 infection is associated with preserved GALT homeostasis and epithelial integrity despite ongoing mucosal viral replication . Mucosal Immunol 2018; 11:236–248.
Thiébaut R, Charpentier C, Damond F, Taieb A, Antoine R, Capeau J, et al. Association of soluble CD14 and inflammatory biomarkers with HIV-2 disease progression . Clin Infect Dis 2012; 55:1417–1425.
Esbjörnsson J, Esbjörnsson J, Månsson F, Kvist A, Isberg PE, Nowroozalizadeh S, et al. Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection . N Engl J Med 2012; 367:224–232.
Jespersen S, Hønge BL, Oliveira I, Medina C, da Silva Té D, Correira FG, et al. Cohort profile: the Bissau HIV Cohort-a cohort of HIV-1, HIV-2 and co-infected patients . Int J Epidemiol 2015; 44:756–763.
Hønge BL, Petersen MS, Jespersen S, Medina C, Té DDS S Kjerulff##B, et al. Bissau HIV Cohort Study Group. T-cell and B-cell perturbations identify distinct differences in HIV-2 compared with HIV-1-induced immunodeficiency . AIDS Lond Engl 2019; 33:1131–1141.
Hønge BL, Petersen MS, Jespersen S, Medina C, Té DDS, Kjerulff B, et al. Bissau HIV Cohort study group. T-cell and B-cell perturbations are similar in ART-naive HIV-1 and HIV-1/2 dually infected patients . AIDS Lond Engl 2019; 33:1143–1153.
Hønge BL, Petersen MS, Olesen R, Møller BK, Erikstrup C. Optimizing recovery of frozen human peripheral blood mononuclear cells for flow cytometry . PLoS One 2017; 12:e0187440.
Møller HJ, Hald K, Moestrup SK. Characterization of an enzyme-linked immunosorbent assay for soluble CD163 . Scand J Clin Lab Invest 2002; 62:293–299.
Kvorning SL, Nielsen MC, Andersen NF, Hokland M, Andersen MN, Møller HJ. Circulating extracellular vesicle-associated CD163 and CD206 in multiple myeloma . Eur J Haematol 2020; 104:409–419.
Hønge B, Jespersen S, Medina C, Té DS, da Silva ZJ, Christiansen M, et al. Bissau HIV Cohort study group. The challenge of discriminating between HIV-1, HIV-2 and HIV-1/2 dual infections . HIV Med 2018; 19:403–410.
Olesen JS, Jespersen S, Da Silva ZJ, Rodrigues A, Erikstrup C, Aaby P, et al. HIV-2 continues to decrease, while HIV-1 is stabilizing in Guinea-Bissau . AIDS 2018; 32:1193–1198.
Hønge BL, Jespersen S, Aunsborg J, Mendes DV, Medina C, da Silva Té D, et al. Bissau HIV cohort study group. High prevalence and excess mortality of late presenters among HIV-1, HIV-2 and HIV-1/2 dually infected patients in Guinea-Bissau - a cohort study from West Africa . Pan Afr Med J 2016; 25:40.
Andersen MN, Hønge BL, Jespersen S, Medina C, da Silva Té D, Laursen A, et al. Bissau HIV Cohort Study Group. Soluble macrophage mannose receptor (sCD206/sMR) as a biomarker in HIV-infection . J Infect Dis 2018; 218:1291–1295.
Embgenbroich M, Zande HJPvan der, Hussaarts L, Schulte-Schrepping J, Pelgrom LR, García-Tardón N, et al. Soluble mannose receptor induces proinflammatory macrophage activation and metaflammation . Proc Natl Acad Sci U S A 2021; 118:e2103304118.
Loonen AJM, Leijtens S, Serin O, Hilbink M, Wever PC, van den Brule AJC, Toonen EJM. Soluble mannose receptor levels in blood correlate to disease severity in patients with community-acquired pneumonia . Immunol Lett 2019; 206:28–32.
Suzuki Y, Shirai M, Asada K, Yasui H, Karayama M, Hozumi H, et al. Macrophage mannose receptor, CD206, predict prognosis in patients with pulmonary tuberculosis . Sci Rep 2018; 8:13129.
Zou R, Gui X, Zhang J, Tian Y, Liu X, Tian M, et al. Association of serum macrophage-mannose receptor CD206 with mortality in idiopathic pulmonary fibrosis . Int Immunopharmacol 2020; 86:106732.
Andersen MN, Andersen NF, Rødgaard-Hansen S, Hokland M, Abildgaard N, Møller HJ. The novel biomarker of alternative macrophage activation, soluble mannose receptor (sMR/sCD206): implications in multiple myeloma . Leuk Res 2015; 39:971–975.
Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, Ségéral E, et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx . Nature 2011; 474:654–657.
Hollenbaugh JA, Montero C, Schinazi RF, Munger J, Kim B. Metabolic profiling during HIV-1 and HIV-2 infection of primary human monocyte-derived macrophages . Virology 2016; 491:106–114.
Gea-Mallorquí E, Zablocki-Thomas L, Maurin M, Jouve M, Rodrigues V, Ruffin N, Benaroch P. HIV-2-infected macrophages produce and accumulate poorly infectious viral particles . Front Microbiol 2020; 11:1603.
Mahdi M, Szojka Z, Mótyán JA, Tőzsér J. Inhibitory effects of HIV-2 Vpx on replication of HIV-1 . J Virol 2018; 92:e00554–e618.
Chougui G, Munir-Matloob S, Matkovic R, Martin MM, Morel M, Lahouassa H, et al. HIV-2/SIV viral protein X counteracts HUSH repressor complex . Nat Microbiol 2018; 3:891–897.
Esbjörnsson J, Månsson F, Kvist A, Isberg PE, Biague AJ, da Silva ZJ, et al. Increased survival among HIV-1 and HIV-2 dual-infected individuals compared to HIV-1 single-infected individuals . AIDS Lond Engl 2014; 28:949–957.
Lindman J, Djalo MA, Biai A, Månsson F, Esbjörnsson J, Jansson M, et al. SWEGUB CORE group. The HIV care continuum and HIV-1 drug resistance among female sex workers: a key population in Guinea-Bissau . AIDS Res Ther 2020; 17:33.